Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Colosseum Skibby Tandlægehus ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 1.5% 0.5%   Bankruptcy risk   2.0% 2.5% 5.0% 3.3% 2.7% 1.9% 8.3% 6.9%   Credit score (0-100)   70 64 44 53 60 68 30 35   Credit rating   A BBB BBB BBB BBB A BB BBB   Credit limit (kDKK)   0.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,167 5,656 5,257 5,365 5,146 5,935 0.0 0.0   EBITDA   383 912 308 484 582 974 0.0 0.0   EBIT   -42.9 -401 -3,466 -306 -282 91.6 0.0 0.0   Pre-tax profit (PTP)   -48.2 -416.2 -3,485.5 -314.6 -299.5 77.6 0.0 0.0   Net earnings   -38.1 -324.6 -3,487.4 -314.6 -299.5 77.6 0.0 0.0   Pre-tax profit without non-rec. items   -48.2 -416 -3,486 -315 -299 77.6 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,283 919 511 544 452 355 0.0 0.0   Shareholders equity total   7,462 7,137 3,650 3,335 3,036 3,113 3,063 3,063   Interest-bearing liabilities   532 119 226 0.0 0.0 89.5 0.0 0.0   Balance sheet total (assets)   9,190 8,514 6,032 5,007 4,409 4,685 3,063 3,063   Net Debt   -190 -964 -69.6 -109 -286 -243 -2,169 -2,169     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,167 5,656 5,257 5,365 5,146 5,935 0.0 0.0   Gross profit growth   0.0% 161.1% -7.1% 2.1% -4.1% 15.3% -100.0% 0.0%   Employees   5 9 9 9 7 9 0 0   Employee growth %   0.0% 80.0% 0.0% 0.0% -22.2% 28.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   9,190 8,514 6,032 5,007 4,409 4,685 3,063 3,063   Balance sheet change%   0.0% -7.3% -29.2% -17.0% -11.9% 6.3% -34.6% 0.0%   Added value   382.6 911.5 308.4 484.0 508.3 974.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   7,543 -2,368 -7,315 -1,340 -1,647 -1,671 -355 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 -5.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -2.0% -7.1% -65.9% -5.7% -5.5% 1.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -0.5% -4.5% -47.7% -5.5% -6.0% 2.0% 0.0% 0.0%   ROI %   -0.5% -5.2% -61.1% -8.1% -8.3% 2.7% 0.0% 0.0%   ROE %   -0.5% -4.4% -64.7% -9.0% -9.4% 2.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   81.3% 84.0% 60.6% 66.8% 69.2% 66.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -49.7% -105.8% -22.6% -22.5% -49.1% -24.9% 0.0% 0.0%   Gearing %   7.1% 1.7% 6.2% 0.0% 0.0% 2.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.0% 5.5% 11.1% 7.7% 0.0% 31.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 1.2 1.1 1.4 2.5 3.1 0.0 0.0   Current Ratio   0.7 1.2 1.2 1.4 2.5 3.1 0.0 0.0   Cash and cash equivalent   722.0 1,083.3 295.6 109.0 285.7 332.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -506.6 281.6 438.6 674.4 1,421.6 2,310.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   77 101 34 54 73 108 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   77 101 34 54 83 108 0 0   EBIT / employee   -9 -45 -385 -34 -40 10 0 0   Net earnings / employee   -8 -36 -387 -35 -43 9 0 0